SPX3,693.23-64.76 -1.72%
DIA295.86-4.66 -1.55%
IXIC10,867.93-198.88 -1.80%

JMP Securities Maintains Market Outperform on Relay Therapeutics, Raises Price Target to $38

JMP Securities analyst Silvan Tuerkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and raises the price target from $35 to $38.

Benzinga · 09/14/2022 07:25
JMP Securities analyst Silvan Tuerkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and raises the price target from $35 to $38.